Karakulska-Prystupiuk, E.; Feliksbrot-Bratosiewicz, M.; Król, M.; Tomaszewska, A.; Jędrzejczak, W.W.; Basak, G.W.
Prevalence of VZV Reactivation and Effectiveness of Vaccination with Recombinant Adjuvanted Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Recipients—A Single-Center Analysis. Infect. Dis. Rep. 2025, 17, 48.
https://doi.org/10.3390/idr17030048
AMA Style
Karakulska-Prystupiuk E, Feliksbrot-Bratosiewicz M, Król M, Tomaszewska A, Jędrzejczak WW, Basak GW.
Prevalence of VZV Reactivation and Effectiveness of Vaccination with Recombinant Adjuvanted Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Recipients—A Single-Center Analysis. Infectious Disease Reports. 2025; 17(3):48.
https://doi.org/10.3390/idr17030048
Chicago/Turabian Style
Karakulska-Prystupiuk, Ewa, Magdalena Feliksbrot-Bratosiewicz, Maria Król, Agnieszka Tomaszewska, Wiesław Wiktor Jędrzejczak, and Grzegorz Władysław Basak.
2025. "Prevalence of VZV Reactivation and Effectiveness of Vaccination with Recombinant Adjuvanted Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Recipients—A Single-Center Analysis" Infectious Disease Reports 17, no. 3: 48.
https://doi.org/10.3390/idr17030048
APA Style
Karakulska-Prystupiuk, E., Feliksbrot-Bratosiewicz, M., Król, M., Tomaszewska, A., Jędrzejczak, W. W., & Basak, G. W.
(2025). Prevalence of VZV Reactivation and Effectiveness of Vaccination with Recombinant Adjuvanted Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Recipients—A Single-Center Analysis. Infectious Disease Reports, 17(3), 48.
https://doi.org/10.3390/idr17030048
